IBDEI1ER ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22773,1,3,0)
;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
;;^UTILITY(U,$J,358.3,22773,1,4,0)
;;=4^C84.15
;;^UTILITY(U,$J,358.3,22773,2)
;;=^5001636
;;^UTILITY(U,$J,358.3,22774,0)
;;=C84.18^^76^978^32
;;^UTILITY(U,$J,358.3,22774,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22774,1,3,0)
;;=3^Sezary Disease,Multiple Site Lymph Nodes
;;^UTILITY(U,$J,358.3,22774,1,4,0)
;;=4^C84.18
;;^UTILITY(U,$J,358.3,22774,2)
;;=^5001639
;;^UTILITY(U,$J,358.3,22775,0)
;;=C84.17^^76^978^33
;;^UTILITY(U,$J,358.3,22775,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22775,1,3,0)
;;=3^Sezary Disease,Spleen
;;^UTILITY(U,$J,358.3,22775,1,4,0)
;;=4^C84.17
;;^UTILITY(U,$J,358.3,22775,2)
;;=^5001638
;;^UTILITY(U,$J,358.3,22776,0)
;;=C84.10^^76^978^34
;;^UTILITY(U,$J,358.3,22776,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22776,1,3,0)
;;=3^Sezary Disease,Unspec Site
;;^UTILITY(U,$J,358.3,22776,1,4,0)
;;=4^C84.10
;;^UTILITY(U,$J,358.3,22776,2)
;;=^5001631
;;^UTILITY(U,$J,358.3,22777,0)
;;=A53.9^^76^978^50
;;^UTILITY(U,$J,358.3,22777,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22777,1,3,0)
;;=3^Syphilis,Unspec
;;^UTILITY(U,$J,358.3,22777,1,4,0)
;;=4^A53.9
;;^UTILITY(U,$J,358.3,22777,2)
;;=^5000310
;;^UTILITY(U,$J,358.3,22778,0)
;;=L90.5^^76^978^18
;;^UTILITY(U,$J,358.3,22778,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22778,1,3,0)
;;=3^Scar-Atrophic/Painful
;;^UTILITY(U,$J,358.3,22778,1,4,0)
;;=4^L90.5
;;^UTILITY(U,$J,358.3,22778,2)
;;=^5009455
;;^UTILITY(U,$J,358.3,22779,0)
;;=L91.0^^76^978^19
;;^UTILITY(U,$J,358.3,22779,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22779,1,3,0)
;;=3^Scar-Hypertrophic/Keloidal
;;^UTILITY(U,$J,358.3,22779,1,4,0)
;;=4^L91.0
;;^UTILITY(U,$J,358.3,22779,2)
;;=^5009459
;;^UTILITY(U,$J,358.3,22780,0)
;;=Z48.02^^76^978^49
;;^UTILITY(U,$J,358.3,22780,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22780,1,3,0)
;;=3^Suture Removal
;;^UTILITY(U,$J,358.3,22780,1,4,0)
;;=4^Z48.02
;;^UTILITY(U,$J,358.3,22780,2)
;;=^5063035
;;^UTILITY(U,$J,358.3,22781,0)
;;=C44.1292^^76^978^4
;;^UTILITY(U,$J,358.3,22781,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22781,1,3,0)
;;=3^SCC Skin Left Eyelid,Incl Canthus
;;^UTILITY(U,$J,358.3,22781,1,4,0)
;;=4^C44.1292
;;^UTILITY(U,$J,358.3,22781,2)
;;=^5157264
;;^UTILITY(U,$J,358.3,22782,0)
;;=C44.1222^^76^978^13
;;^UTILITY(U,$J,358.3,22782,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22782,1,3,0)
;;=3^SCC Skin Right Eyelid,Incl Canthus
;;^UTILITY(U,$J,358.3,22782,1,4,0)
;;=4^C44.1222
;;^UTILITY(U,$J,358.3,22782,2)
;;=^5157262
;;^UTILITY(U,$J,358.3,22783,0)
;;=Z76.89^^76^978^24
;;^UTILITY(U,$J,358.3,22783,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22783,1,3,0)
;;=3^Self Injection Training
;;^UTILITY(U,$J,358.3,22783,1,4,0)
;;=4^Z76.89
;;^UTILITY(U,$J,358.3,22783,2)
;;=^5063304
;;^UTILITY(U,$J,358.3,22784,0)
;;=Z13.89^^76^978^35
;;^UTILITY(U,$J,358.3,22784,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22784,1,3,0)
;;=3^Skin Assessment
;;^UTILITY(U,$J,358.3,22784,1,4,0)
;;=4^Z13.89
;;^UTILITY(U,$J,358.3,22784,2)
;;=^5062720
;;^UTILITY(U,$J,358.3,22785,0)
;;=L91.8^^76^978^40
;;^UTILITY(U,$J,358.3,22785,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22785,1,3,0)
;;=3^Skin Tag
;;^UTILITY(U,$J,358.3,22785,1,4,0)
;;=4^L91.8
;;^UTILITY(U,$J,358.3,22785,2)
;;=^5009460
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1ER 3755 printed Sep 23, 2025@19:43:18 Page 2
IBDEI1ER ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22773,1,3,0)
+2 ;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
+3 ;;^UTILITY(U,$J,358.3,22773,1,4,0)
+4 ;;=4^C84.15
+5 ;;^UTILITY(U,$J,358.3,22773,2)
+6 ;;=^5001636
+7 ;;^UTILITY(U,$J,358.3,22774,0)
+8 ;;=C84.18^^76^978^32
+9 ;;^UTILITY(U,$J,358.3,22774,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,22774,1,3,0)
+12 ;;=3^Sezary Disease,Multiple Site Lymph Nodes
+13 ;;^UTILITY(U,$J,358.3,22774,1,4,0)
+14 ;;=4^C84.18
+15 ;;^UTILITY(U,$J,358.3,22774,2)
+16 ;;=^5001639
+17 ;;^UTILITY(U,$J,358.3,22775,0)
+18 ;;=C84.17^^76^978^33
+19 ;;^UTILITY(U,$J,358.3,22775,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,22775,1,3,0)
+22 ;;=3^Sezary Disease,Spleen
+23 ;;^UTILITY(U,$J,358.3,22775,1,4,0)
+24 ;;=4^C84.17
+25 ;;^UTILITY(U,$J,358.3,22775,2)
+26 ;;=^5001638
+27 ;;^UTILITY(U,$J,358.3,22776,0)
+28 ;;=C84.10^^76^978^34
+29 ;;^UTILITY(U,$J,358.3,22776,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,22776,1,3,0)
+32 ;;=3^Sezary Disease,Unspec Site
+33 ;;^UTILITY(U,$J,358.3,22776,1,4,0)
+34 ;;=4^C84.10
+35 ;;^UTILITY(U,$J,358.3,22776,2)
+36 ;;=^5001631
+37 ;;^UTILITY(U,$J,358.3,22777,0)
+38 ;;=A53.9^^76^978^50
+39 ;;^UTILITY(U,$J,358.3,22777,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,22777,1,3,0)
+42 ;;=3^Syphilis,Unspec
+43 ;;^UTILITY(U,$J,358.3,22777,1,4,0)
+44 ;;=4^A53.9
+45 ;;^UTILITY(U,$J,358.3,22777,2)
+46 ;;=^5000310
+47 ;;^UTILITY(U,$J,358.3,22778,0)
+48 ;;=L90.5^^76^978^18
+49 ;;^UTILITY(U,$J,358.3,22778,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,22778,1,3,0)
+52 ;;=3^Scar-Atrophic/Painful
+53 ;;^UTILITY(U,$J,358.3,22778,1,4,0)
+54 ;;=4^L90.5
+55 ;;^UTILITY(U,$J,358.3,22778,2)
+56 ;;=^5009455
+57 ;;^UTILITY(U,$J,358.3,22779,0)
+58 ;;=L91.0^^76^978^19
+59 ;;^UTILITY(U,$J,358.3,22779,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,22779,1,3,0)
+62 ;;=3^Scar-Hypertrophic/Keloidal
+63 ;;^UTILITY(U,$J,358.3,22779,1,4,0)
+64 ;;=4^L91.0
+65 ;;^UTILITY(U,$J,358.3,22779,2)
+66 ;;=^5009459
+67 ;;^UTILITY(U,$J,358.3,22780,0)
+68 ;;=Z48.02^^76^978^49
+69 ;;^UTILITY(U,$J,358.3,22780,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,22780,1,3,0)
+72 ;;=3^Suture Removal
+73 ;;^UTILITY(U,$J,358.3,22780,1,4,0)
+74 ;;=4^Z48.02
+75 ;;^UTILITY(U,$J,358.3,22780,2)
+76 ;;=^5063035
+77 ;;^UTILITY(U,$J,358.3,22781,0)
+78 ;;=C44.1292^^76^978^4
+79 ;;^UTILITY(U,$J,358.3,22781,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,22781,1,3,0)
+82 ;;=3^SCC Skin Left Eyelid,Incl Canthus
+83 ;;^UTILITY(U,$J,358.3,22781,1,4,0)
+84 ;;=4^C44.1292
+85 ;;^UTILITY(U,$J,358.3,22781,2)
+86 ;;=^5157264
+87 ;;^UTILITY(U,$J,358.3,22782,0)
+88 ;;=C44.1222^^76^978^13
+89 ;;^UTILITY(U,$J,358.3,22782,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,22782,1,3,0)
+92 ;;=3^SCC Skin Right Eyelid,Incl Canthus
+93 ;;^UTILITY(U,$J,358.3,22782,1,4,0)
+94 ;;=4^C44.1222
+95 ;;^UTILITY(U,$J,358.3,22782,2)
+96 ;;=^5157262
+97 ;;^UTILITY(U,$J,358.3,22783,0)
+98 ;;=Z76.89^^76^978^24
+99 ;;^UTILITY(U,$J,358.3,22783,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,22783,1,3,0)
+102 ;;=3^Self Injection Training
+103 ;;^UTILITY(U,$J,358.3,22783,1,4,0)
+104 ;;=4^Z76.89
+105 ;;^UTILITY(U,$J,358.3,22783,2)
+106 ;;=^5063304
+107 ;;^UTILITY(U,$J,358.3,22784,0)
+108 ;;=Z13.89^^76^978^35
+109 ;;^UTILITY(U,$J,358.3,22784,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,22784,1,3,0)
+112 ;;=3^Skin Assessment
+113 ;;^UTILITY(U,$J,358.3,22784,1,4,0)
+114 ;;=4^Z13.89
+115 ;;^UTILITY(U,$J,358.3,22784,2)
+116 ;;=^5062720
+117 ;;^UTILITY(U,$J,358.3,22785,0)
+118 ;;=L91.8^^76^978^40
+119 ;;^UTILITY(U,$J,358.3,22785,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,22785,1,3,0)
+122 ;;=3^Skin Tag
+123 ;;^UTILITY(U,$J,358.3,22785,1,4,0)
+124 ;;=4^L91.8
+125 ;;^UTILITY(U,$J,358.3,22785,2)
+126 ;;=^5009460
